Potassium Dehydroandrographolide Succinate Injection Market Report – Research, Industry Analysis Reports and Market Demands

Global Potassium Dehydroandrographolide Succinate Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Potassium Dehydroandrographolide Succinate Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 10ml:0.2g
- 1.3.3 5ml:0.1g
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Potassium Dehydroandrographolide Succinate Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Other
1.5 Global Potassium Dehydroandrographolide Succinate Injection Market Size & Forecast
- 1.5.1 Global Potassium Dehydroandrographolide Succinate Injection Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Potassium Dehydroandrographolide Succinate Injection Sales Quantity (2021-2032)
- 1.5.3 Global Potassium Dehydroandrographolide Succinate Injection Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Potassium Dehydroandrographolide Succinate Injection by Manufacturer

3.1 Global Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Manufacturer (2021-2026)
3.2 Global Potassium Dehydroandrographolide Succinate Injection Revenue by Manufacturer (2021-2026)
3.3 Global Potassium Dehydroandrographolide Succinate Injection Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Potassium Dehydroandrographolide Succinate Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Potassium Dehydroandrographolide Succinate Injection Manufacturer Market Share in 2025
- 3.4.3 Top 6 Potassium Dehydroandrographolide Succinate Injection Manufacturer Market Share in 2025
3.5 Potassium Dehydroandrographolide Succinate Injection Market: Overall Company Footprint Analysis
- 3.5.1 Potassium Dehydroandrographolide Succinate Injection Market: Region Footprint
- 3.5.2 Potassium Dehydroandrographolide Succinate Injection Market: Company Product Type Footprint
- 3.5.3 Potassium Dehydroandrographolide Succinate Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Potassium Dehydroandrographolide Succinate Injection Market Size by Region
- 4.1.1 Global Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Region (2021-2032)
- 4.1.2 Global Potassium Dehydroandrographolide Succinate Injection Consumption Value by Region (2021-2032)
- 4.1.3 Global Potassium Dehydroandrographolide Succinate Injection Average Price by Region (2021-2032)
4.2 North America Potassium Dehydroandrographolide Succinate Injection Consumption Value (2021-2032)
4.3 Europe Potassium Dehydroandrographolide Succinate Injection Consumption Value (2021-2032)
4.4 Asia-Pacific Potassium Dehydroandrographolide Succinate Injection Consumption Value (2021-2032)
4.5 South America Potassium Dehydroandrographolide Succinate Injection Consumption Value (2021-2032)
4.6 Middle East & Africa Potassium Dehydroandrographolide Succinate Injection Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Type (2021-2032)
5.2 Global Potassium Dehydroandrographolide Succinate Injection Consumption Value by Type (2021-2032)
5.3 Global Potassium Dehydroandrographolide Succinate Injection Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Application (2021-2032)
6.2 Global Potassium Dehydroandrographolide Succinate Injection Consumption Value by Application (2021-2032)
6.3 Global Potassium Dehydroandrographolide Succinate Injection Average Price by Application (2021-2032)

7 North America

7.1 North America Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Type (2021-2032)
7.2 North America Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Application (2021-2032)
7.3 North America Potassium Dehydroandrographolide Succinate Injection Market Size by Country
- 7.3.1 North America Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Country (2021-2032)
- 7.3.2 North America Potassium Dehydroandrographolide Succinate Injection Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Type (2021-2032)
8.2 Europe Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Application (2021-2032)
8.3 Europe Potassium Dehydroandrographolide Succinate Injection Market Size by Country
- 8.3.1 Europe Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Potassium Dehydroandrographolide Succinate Injection Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Potassium Dehydroandrographolide Succinate Injection Market Size by Region
- 9.3.1 Asia-Pacific Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Potassium Dehydroandrographolide Succinate Injection Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Type (2021-2032)
10.2 South America Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Application (2021-2032)
10.3 South America Potassium Dehydroandrographolide Succinate Injection Market Size by Country
- 10.3.1 South America Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Country (2021-2032)
- 10.3.2 South America Potassium Dehydroandrographolide Succinate Injection Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Potassium Dehydroandrographolide Succinate Injection Market Size by Country
- 11.3.1 Middle East & Africa Potassium Dehydroandrographolide Succinate Injection Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Potassium Dehydroandrographolide Succinate Injection Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Potassium Dehydroandrographolide Succinate Injection Market Drivers
12.2 Potassium Dehydroandrographolide Succinate Injection Market Restraints
12.3 Potassium Dehydroandrographolide Succinate Injection Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Potassium Dehydroandrographolide Succinate Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Potassium Dehydroandrographolide Succinate Injection
13.3 Potassium Dehydroandrographolide Succinate Injection Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Potassium Dehydroandrographolide Succinate Injection Typical Distributors
14.3 Potassium Dehydroandrographolide Succinate Injection Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Potassium Dehydroandrographolide Succinate Injection market size was valued at US$ 36.2 million in 2025 and is forecast to a readjusted size of US$ 52.41 million by 2032 with a CAGR of 5.5% during review period.
Potassium Dehydroandrographolide Succinate Injection is a traditional Chinese medicine preparation. Its main ingredient is chlorogenic acid, an effective ingredient extracted from honeysuckle, a plant of the Caprifoliaceae family. After chemical modification, it is obtained as a succinylated derivative, namely andrographolide succinate. This drug has pharmacological effects such as clearing away heat and detoxification, anti-inflammatory, antibacterial and antiviral. It is mainly used clinically to treat symptoms such as fever, sore throat, cough, etc. caused by exogenous wind-heat, as well as diseases such as acute tonsillitis and upper respiratory tract infection.
This report is a detailed and comprehensive analysis for global Potassium Dehydroandrographolide Succinate Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Potassium Dehydroandrographolide Succinate Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Potassium Dehydroandrographolide Succinate Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Potassium Dehydroandrographolide Succinate Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Potassium Dehydroandrographolide Succinate Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Potassium Dehydroandrographolide Succinate Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Potassium Dehydroandrographolide Succinate Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sichuan Meida Kanghuakang Pharmaceutical Co., Ltd., Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd., Sinopharm Group Yibin Pharmaceutical Co., Ltd., Harbin Pharmaceutical Group Sanjin Pharmaceutical Co., Ltd., Xi'an Lijun Pharmaceutical Co., Ltd., Henan Furen Huaiqingtang Pharmaceutical Co., Ltd., Chengdu Tiantaishan Pharmaceutical Co., Ltd., Changshu Leiyunshang Pharmaceutical Co., Ltd., Chengdu Haitong Pharmaceutical Co., Ltd., Sucheng Pharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Potassium Dehydroandrographolide Succinate Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
10ml:0.2g
5ml:0.1g
Market segment by Application
Hospital
Clinic
Other
Major players covered
Sichuan Meida Kanghuakang Pharmaceutical Co., Ltd.
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Sinopharm Group Yibin Pharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Sanjin Pharmaceutical Co., Ltd.
Xi'an Lijun Pharmaceutical Co., Ltd.
Henan Furen Huaiqingtang Pharmaceutical Co., Ltd.
Chengdu Tiantaishan Pharmaceutical Co., Ltd.
Changshu Leiyunshang Pharmaceutical Co., Ltd.
Chengdu Haitong Pharmaceutical Co., Ltd.
Sucheng Pharmaceutical Co., Ltd.
Chongqing Laimi Pharmaceutical Co., Ltd.
Jilin Aodong Taonan Pharmaceutical Co., Ltd.
Liaoning Keji Pharmaceutical Co., Ltd.
Heilongjiang Ruige Pharmaceutical Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Potassium Dehydroandrographolide Succinate Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Potassium Dehydroandrographolide Succinate Injection, with price, sales quantity, revenue, and global market share of Potassium Dehydroandrographolide Succinate Injection from 2021 to 2026.
Chapter 3, the Potassium Dehydroandrographolide Succinate Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Potassium Dehydroandrographolide Succinate Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Potassium Dehydroandrographolide Succinate Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Potassium Dehydroandrographolide Succinate Injection.
Chapter 14 and 15, to describe Potassium Dehydroandrographolide Succinate Injection sales channel, distributors, customers, research findings and conclusion.

Buy now